Close Menu

NEW YORK (GenomeWeb) – Rosetta Genomics today reported a 115 percent jump in its second quarter revenues, due to increased sales of the company's RosettaGX Reveal assay for the classification of indeterminate thyroid nodules (ITN).

The company also disclosed that the previously announced $2.9 million sale of its PersonalizeDx business has been delayed after the buyer, Pragmin Prognosis, failed to complete the transaction.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
26
Sponsored by
PerkinElmer

This webinar will address the current status and future directions for massively high-throughput genomics for plant and animal breeding and research.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

Mar
28
Sponsored by
Qiagen

The Human Gene Mutation Database (HGMD) is a manually curated, comprehensive collection of disease-causing, germline mutations. Since 1996, a team of experts has manually catalogued over a quarter of a million mutations for the database.  

Apr
11
Sponsored by
Bionano Genomics

This webinar will review a recent study that applied whole-genome sequencing and optical genome mapping to identify a large number of previously undetected somatic structural variants in leukemia samples.